Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The PEWS implementation study will be undertaken with the following objectives:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Inpatient pediatric oncology patients | Other | All patients admitted to the pediatric oncology ward will be in the cohort |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pediatric early warning scoring system and resuscitation curriculum | Other | teaching resuscitation to medical providers and implementing a scoring tool to help identify patients at risk for clinical deterioration in an inpatient setting |
| Measure | Description | Time Frame |
|---|---|---|
| Elevated Pediatric Early Warning Score (PEWS) | frequency of patients whose PEWS score indicates 'risk for clinical deterioration' and receive a clinical intervention. PEWS 3 or greater (Scale is PEWS 0-6) is defined as at risk for clinical deterioration with a higher score concerning for worse clinical outcome. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Time to antibiotics | Time to antibiotics defined as time from documented vital signs/PEWS to time of antibiotic administration measured in minutes | 1 year |
| Time to IV fluid bolus | Time to fluids defined as time from documented vital signs/PEWS to time of documented IV fluid bolus measured in minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michelle Niescierenko, MD MPH | Boston Children's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beit Jala Hospital | Bethlehem | Palestinian Territories | ||||
| Rantisi Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| Volume of IV fluids | Volume of fluids received defined as volume given up to 60 minutes after the initiation of the first fluid bolus measured in milliliters | 1 year |
| Length of stay | Length of stay for all patients admitted to the inpatient ward | 1 year |
| Gaza |
| Palestinian Territories |